PROVENTIV THERAPEUTICS
Proventiv Therapeutics, L.L.C. develops and commercializes pharmaceutical products to treat and prevent the clinical consequences of diseases and disorders related to vitamin D deficiency.
PROVENTIV THERAPEUTICS
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2005-01-01
Address:
Fitchburg, Wisconsin, United States
Country:
United States
Status:
Active
Contact:
(608)239-0168
Similar Organizations
Gemin X Pharmaceuticals
Gemin X Pharmaceuticals develops and commercializes targeted cancer therapeutics to improve the lives of patients.
Ichor Therapeutics
Ichor Therapeutics develops and commercializes research and clinical products in the field of regenerative medicine.
Secant Therapeutics
Secant Therapeutics develops a percutaneous transcatheter direct plication annuloplasty (DPA) device.
More informations about "Proventiv Therapeutics"
Proventive Therapeutics - PitchBook
Developer of proprietary products to treat and prevent the clinical consequences of diseases and disorders related to vitamin D deficiency. The company owns patent applications for vitamin D โฆSee details»
Proventiv Therapeutics - Overview, News & Similar companies
Who is Proventiv Therapeutics. Proventiv Therapeutics LLC is a company that operates in the Biotechnology industry. It employs 6-10 people and has $1M-$5M of revenue. The company is โฆSee details»
Cytochroma acquires Proventiv Therapeutics - 2006-06-29
Proventiv Therapeutics Proventiv Therapeutics develops and commercializes pharmaceutical products to treat and prevent the clinical consequences of diseases. Acquiring Organization: โฆSee details»
Proventiv Therapeutics LLC - Company Profile and News
Company profile page for Proventiv Therapeutics LLC including stock price, company news, executives, board members, and contact informationSee details»
Proventiv Therapeutics - Crunchbase
Proventiv Therapeutics develops and commercializes pharmaceutical products to treat and prevent the clinical consequences of diseases.See details»
Proventiv Therapeutics LLC Company Profile, Financial and โฆ
Proventiv Therapeutics, L.L.C. develops and commercializes pharmaceutical products to treat and prevent the clinical consequences of diseases and disorders related to vitamin D deficiency. It โฆSee details»
Proventiv Therapeutics LLC:Company Profile & Technical Research ...
Proventiv Therapeutics LLC is headquartered in United States Wisconsin. Proventiv Therapeutics LLC was founded in 2005. Proventiv Therapeutics LLC has a total of 41 patents . Related โฆSee details»
PROVENTIV THERAPEUTICS LLC innovation strategy - GoodIP
PROVENTIV THERAPEUTICS LLC has a total of 19 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2006. It filed its patents most often in โฆSee details»
010855994 EIN/TAX ID | PROVENTIV THERAPEUTICS, LLC | ,
PROVENTIV THERAPEUTICS, LLC: Conformed submission company name, business name, organization name, etc CIK: N/S (NOT SPECIFIED) Company's Central Index Key (CIK). The โฆSee details»
EX-2.10 - SEC.gov
PROVENTIV THERAPEUTICS, LLC . CYTOCHROMA CAYMAN ISLANDS, LTD., OPKO HEALTH, INC. and . OPKO IP HOLDINGS, INC. January 8, 2013 . TABLE OF CONTENTS . โฆSee details»
PROVENTIV THERAPEUTICS, LLC Inventions, Patents ... - Justia โฆ
Abstract: The method of treating elevated blood levels of iPTH by increasing or maintaining blood concentrations of both 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D in a patient by โฆSee details»
Patents Assigned to Proventiv Therapeutics, LLC - Justia Patents โฆ
Patents Assigned to Proventiv Therapeutics, LLC Methods and compounds for vitamin D therapy. Patent number: 8592401 Abstract: Methods and compositions comprising 1,25 โฆSee details»
What is Proventiv Therapeutics? Company Culture, Mission, Values
Proventiv Therapeutics. Is this your company? This employer has not claimed their Employer Profile and is missing out on connecting with our community. Connect with our community. โฆSee details»
Cytochroma Inc. Acquires Proventiv Therapeutics To ... - BioSpace
Cytochroma Inc. Acquires Proventiv Therapeutics To ... - BioSpaceSee details»
Working at Proventiv Therapeutics - Glassdoor
See what employees say it's like to work at Proventiv Therapeutics. Salaries, reviews, and more - all posted by employees working at Proventiv Therapeutics.See details»
Effects of probiotics on gut microbiota: mechanisms of intestinal ...
Probiotics have been proposed as preventive and therapeutic measures, in order to restore the healthy composition and function of the gut microbiome. However, data from human โฆSee details»
WHO preferred product characteristics for therapeutic HPV vaccines
Jul 3, 2024 Therapeutic vaccines for human papillomavirus (HPV) are currently in development and could be an important new tool in the fight against cervical cancer. Unlike existing โฆSee details»
Biotherapeutic products - World Health Organization (WHO)
WHO published โQuality control of biologicals produced by recombinant DNA techniquesโ in 1983 (Bulletin of the World Health Organization, 61). The article reviewed the application of โฆSee details»
An orally bioavailable SARS-CoV-2 main protease inhibitor ... - AAAS
Mar 13, 2024 The toolkit for preventing and treating patients with COVID-19 has expanded greatly since the pandemic began. Some of the most effective therapeutics for COVID-19 and, โฆSee details»
Marker Therapeutics Awarded $9.5 Million Grant from the Cancer ...
8 hours ago โWe are pleased to receive $9.5 million from CPRIT to explore MT-601 in our Phase 1 study in patients with pancreatic cancer,โ said Juan Vera, M.D., President and CEO of โฆSee details»